Skip to main content

News

You are here

UM Ventures News

UM Ventures News
Partner News

UM Baltimore Grants Pataigin, LLC, Rights to Technology Developed for Rapid, Point-of-Care Identification of Dangerous Pathogens

Tuesday, December 8, 2015

Remedy Pharmaceuticals

Remedy Pharmaceuticals Completes $9 Million Financing

Tuesday, December 1, 2015

School of Medicine Researchers Work to Develop GammaPod for Breast Cancer Therapy

Tuesday, November 24, 2015

Profectus Preclinical Data of Multi-Component Vaccine Provides Protection Against Ebola & Marburg Virus

Thursday, November 19, 2015

MedImmune

MedImmune Forms New Research Initiative with UM School of Pharmacy's Dr. Bruce Yu

Tuesday, November 3, 2015

UM Baltimore Grants Glycocept Rights to a Technology Designed to Increase the Efficacy of therapeutic Monoclonal Antibodies

Wednesday, October 28, 2015

Educational & Scientific, LLC and University of Maryland, Baltimore Sign an Agreement to Develop and Commercialize Novel Treatment for Major Cancers

Wednesday, October 28, 2015

Meenan Unveils ‘New Frontier for Innovation’

Tuesday, October 27, 2015

IMAGE: Wolfgang Losert, PhD, of UMCP, Lisa Shulman, MD, of the SOM, and Amitabh Varshney, PhD, of UMCP listen as their 2015 grant awards are announced.

2015 UMB-UMCP Seed Grants Announced

Friday, October 16, 2015

Harpoon Medical Reports Results of Ten Patient Trial of its Repair System for Treatment of Mitral Valve Regurgitation

Friday, October 16, 2015

Pages